V

Virax Biolabs Group Limited
D

VRAX

2.08000
USD
0.06
(2.97%)
Market Closed
Volume
0
EPS
0
Div Yield
-
P/E
-1
Market Cap
9,031,268
News

Title: Virax Biolabs Group Limited

Sector: Healthcare
Industry: Biotechnology
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developinga proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.